Cripto Is a Noncompetitive Activin Antagonist That Forms Analogous Signaling Complexes with Activin and NodalJonathan A. Kelber, Peter C. Gray|Journal of Biological Chemistry|2007Cited by 67
A SNAI2-PEAK1-INHBA stromal axis drives progression and lapatinib resistance in HER2-positive breast cancer by supporting subpopulations of tumor cells positive for antiapoptotic and stress signaling markersSarkis Hamalian, Jonathan A. Kelber, Eric Vickers et al.|Oncogene|2021Cited by 30
Fibronectin, DHPS and SLC3A2 Signaling Cooperate to Control Tumor Spheroid Growth, Subcellular eIF5A1/2 Distribution and CDK4/6 Inhibitor ResistanceCameron Geller, Jonathan A. Kelber|bioRxiv (Cold Spring Harbor Laboratory)|2023Cited by 4
Multidimensional screening of pancreatic cancer spheroids reveals vulnerabilities in mitotic and cell-matrix adhesion signaling that associate with metastatic progression and decreased patient survivalAlbert-Fred Aquino, Jonathan A. Kelber|Biochemical and Biophysical Research Communications|2024Cited by 2
Abstract 2140: Mesenchymal stromal cells expressing a PEAK1/Cripto axis sustain pro-survival NF-κB signaling in adjacent tumor cells to promote disease progression and therapy resistanceSarkis Hamalian, Jonathan A. Kelber, Robert Güth et al.|Cancer Research|2018Cited by 0